Inadvertent Chlorpropamide Hypoglycemia — No Longer Once in a Blue Moon?
- 22 January 1987
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 316 (4) , 223
- https://doi.org/10.1056/nejm198701223160418
Abstract
To the Editor: Until November 1984, Diabinese (Pfizer Laboratories) was the only brand of chlorpropamide marketed in the United States. The highly characteristic pill was easily recognized by patients, pharmacists, and physicians by virtue of its unique half-moon shape and bright blue color. These dramatic properties may also have served to prevent its inadvertent use in nondiabetic patients. We wish to report two cases in which a generic form of chlorpropamide (a plain white tablet) was administered by mistake to elderly nondiabetic patients, who presented with severe, unexplained hypoglycemia.The first patient was an 82-year-old Jamaican woman with a history . . .Keywords
This publication has 6 references indexed in Scilit:
- Diabinese® and Dialume®Annals of Internal Medicine, 1982
- Pseudoinsulinoma Syndrome from Inadvertent Tolazamide IngestionAnnals of Internal Medicine, 1980
- Hypoglycemia from the Inadvertent Use of Oral Hypoglycemic AgentsAnnals of Internal Medicine, 1980
- Inadvertently Induced HypoglycemiaJAMA, 1978